# Exosomes and IBD

# References

- Exosomes as drug delivery vehicles for Parkinson’s disease therapy. Journal of Controlled Release 207, 18–30.
- H ELMBY, H. (2015). Human helminth therapy to treat inflammatory disorders- where do we stand? BMC Immunology 16, 12.
- H OCK, A., M IYAKE, H., L I, B., LEE, C., ERMINI, L., K OIKE, Y., C HEN, Y., MA¨ A¨ TTA¨ NEN, P., ZANI, A. & P IERRO, A. (2017). Breast milk-derived exosomes promote intestinal epithelial cell growth. Journal of Pediatric Surgery 52, 755–759.
- H OOD, J. L. (2016). Post isolation modification of exosomes for nanomedicine applications. Nanomedicine 11, 1745–1756.
- H U, G., G ONG, A.-Y., R OTH, A. L., H UANG, B. Q., W ARD, H. D., ZHU, G., LA R USSO, N. F., H ANSON, N. D. & C HEN, X.-M. (2013). Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathogens 9, e1003261.
- I SOLA, A. & C HEN, S. (2016). Exosomes: the messengers of health and disease. Current Neuropharmacology 15, 157–165.
- J EPPESEN, D. K., F ENIX, A. M., F RANKLIN, J. L., HIGGINBOTHAM, J. N., Z HANG, Q., ZIMMERMAN, L. J., LIEBLER, D. C., P ING, J., LIU, Q., EVANS, R., F ISSELL, W. H., P ATTON, J. G., ROME, L. H., BURNETTE, D. T. & C OFFEY, R. J. (2019). Reassessment of exosome composition. Cell 177, 428–445.e18.
- J IA, Y., C HEN, Y., WANG, Q., J AYASINGHE, U., LUO, X., W EI, Q., W ANG, J., X IONG, H., CHEN, C., XU, B., H U, W., W ANG, L., ZHAO, W. & Z HOU, J. (2017). Exosome: emerging biomarker in breast cancer. Oncotarget 8, 41717–41733.
- J IANG, L., SHEN, Y., G UO, D., Y ANG, D., L IU, J., F EI, X., YANG, Y., Z HANG, B., LIN, Z., YANG, F., W ANG, X., W ANG, K., W ANG, J. & C AI, Z. (2016). EpCAM-dependent extracellular vesicles from intestinal epithelial cells maintain intestinal tract immune balance. Nature Communications 7, 13045.
- J IANG, X.-C. & G AO, J.-Q. (2017). Exosomes as novel bio-carriers for gene and drug delivery. International Journal of Pharmaceutics 521, 167–175.
- J U, S., M U, J., D OKLAND, T., Z HUANG, X., W ANG, Q., J IANG, H., XIANG, X., DENG, Z.-B., W ANG, B., Z HANG, L., R OTH, M., W ELTI, R., MOBLEY, J., J UN, Y., MILLER, D. & ZHANG, H. G. (2013). Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Molecular Therapy 21, 1345–1357.
- KALLURI, R. (2016). The biology and function of exosomes in cancer. The Journal of Clinical Investigation 126, 1208–1215.
- K ANG, J., Z HANG, Z., W ANG, J., W ANG, G., Y AN, Y., Q IAN, H., Z HANG, X., XU, W. & MAO, F. (2019). hucMSCs attenuate IBD through releasing miR148b-5p to inhibit the expression of 15-lox-1 in macrophages. Mediators of Inflammation 2019, 1–16.
- K EERTHIKUMAR, S., C HISANGA, D., A RIYARATNE, D., A L S AFFAR, H., ANAND, S., ZHAO, K., SAMUEL, M., P ATHAN, M., J OIS, M., C HILAMKURTI, N., GANGODA, L. & MATHIVANAN, S. (2016). ExoCarta: a web-based compendium of exosomal cargo. Journal of Molecular Biology 428, 688–692.
- K IBRIA, G., R AMOS, E. K., W AN, Y., G IUS, D. R. & LIU, H. (2018). Exosomes as a drug delivery system in cancer therapy: potential and challenges. Molecular Pharmaceutics 15, 3625–3633.
- K UBIRITOVA, Z., R ADVANSZKY, J. & G ARDLIK, R. (2019). Cell-free nucleic acids and their emerging role in the pathogenesis and clinical management of inflammatory bowel disease. International Journal of Molecular Sciences 20, 3662.
- K URIYAN, A. E., A LBINI, T. A., T OWNSEND, J. H., R ODRIGUEZ, M., P ANDYA, H. K., LEONARD, R. E., P ARROTT, M. B., ROSENFELD, P. J., F LYNN, H. W. & GOLDBERG, J. L. (2017). Vision loss after intravitreal injection of autologous “stem cells” for AMD. New England Journal of Medicine 376, 1047–1053.
- L AROUI, H., D ALMASSO, G., N GUYEN, H. T. T., Y AN, Y., S ITARAMAN, S. V. & MERLIN, D. (2010). Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Gastroenterology 138, 843–853.e2.
- L AWRANCE, I. C., ROGLER, G., BAMIAS, G., B REYNAERT, C., F LORHOLMEN, J., P ELLINO, G., R EIF, S., S PECA, S. & L ATELLA, G. (2015). Cellular and molecular mediators of intestinal fibrosis. Journal of Crohn’s and Colitis 11, 1491–1503. https://doi.org/10.1016/j.crohns.2014.09.008
- L E D OARE, K., H OLDER, B., BASSETT, A. & P ANNARAJ, P. S. (2018). Mother’s milk: a purposeful contribution to the development of the infant microbiota and immunity. Frontiers in Immunology 9, 361.
- L EONI, G., N EUMANN, P.-A., K AMALY, N., QUIROS, M., N ISHIO, H., J ONES, H. R., SUMAGIN, R., H ILGARTH, R. S., A LAM, A., F REDMAN, G., A RGYRIS, I., R IJCKEN, E., K USTERS, D., R EUTELINGSPERGER, C., P ERRETTI, M., P ARKOS, C. A., F AROKHZAD, O. C., N EISH, A. S. & N USRAT, A. (2015). Annexin A1–containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. Journal of Clinical Investigation 125, 1215–1227.
- L I, S., L I, Y., CHEN, B., Z HAO, J., Y U, S., T ANG, Y., Z HENG, Q., L I, Y., W ANG, P., H E, X. & H UANG, S. (2018a). exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids Research 46, D106–D112.
- L I, Z., W ANG, Y., X IAO, K., X IANG, S., LI, Z. & W ENG, X. (2018b). Emerging role of exosomes in the joint diseases. Cellular Physiology and Biochemistry 47, 2008–2017.
- L IAO, W., DU, Y., Z HANG, C., P AN, F., YAO, Y., Z HANG, T. & P ENG, Q. (2019). Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomaterialia 86, 1–14.
- L IU, H., L IANG, Z., WANG, F., Z HOU, C., ZHENG, X., H U, T., H E, X., W U, X. & L AN, P. (2019). Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. JCI Insight 4, e131273.
- L IU, R., T ANG, A., W ANG, X., CHEN, X., Z HAO, L., X IAO, Z. & S HEN, S. (2018a). Inhibition of lncRNA NEAT1 suppresses the inflammatory response in IBD by modulating the intestinal epithelial barrier and by exosome-mediated polarization of macrophages. International Journal of Molecular Medicine 42, 2903–2913.
- L IU, S., DA CUNHA, A. P., R EZENDE, R. M., C IALIC, R., W EI, Z., BRY, L., C OMSTOCK, L. E., G ANDHI, R. & W EINER, H. L. (2016). The host shapes the gut microbiota via fecal microRNA. Cell Host & Microbe 19, 32–43.
- L IU, Z., CAUVI, D. M., B ERNARDINO, E. M. A., L ARA, B., LIZARDO, R. E., HAWISHER, D., BICKLER, S. & D E MAIO, A. (2018b). Isolation and characterization of human urine extracellular vesicles. Cell Stress and Chaperones 23, 943–953.
- M ALLEGOL, J., V AN N IEL, G., LEBRETON, C., L EPELLETIER, Y., C ANDALH, C., DUGAVE, C., H EATH, J. K., RAPOSO, G., CERF –B ENSUSSAN, N. & H EYMAN, M. (2007). T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells. Gastroenterology 132, 1866–1876.
- M ALM, T., LOPPI, S. & KANNINEN, K. M. (2016). Exosomes in Alzheimer’s disease. Neurochemistry International 97, 193–199.
- MAO, F., KANG, J. J., CAI, X., DING, N. F., WU, Y. B., YAN, Y. M., QIAN, H., ZHANG, X. & XU, W. R. (2017a). Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Contemporary Oncology 21, 91–97.
- M AO, F., W U, Y., T ANG, X. & KANG, J. (2017b). Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice. BioMed Research International 2017, 1–12.
- M ARAFINI, I., S EDDA, S., D INALLO, V. & MONTELEONE, G. (2019). Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opinion on Biological Therapy 19, 1207–1217.
- M ARTIN, C., P ATEL, M., W ILLIAMS, S., A RORA, H., B RAWNER, K. & S IMS, B. (2018). Human breast milk-derived exosomes attenuate cell death in intestinal epithelial cells. Innate Immunity 24, 278–284.
- M ATHIVANAN, S., F AHNER, C. J., R EID, G. E. & S IMPSON, R. J. (2012). ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Research 40, D1241–D1244.
- M CK ENNA, L. B., SCHUG, J., V OUREKAS, A., M C K ENNA, J. B., B RAMSWIG, N. C., F RIEDMAN, J. R. & K AESTNER, K. H. (2010). MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 139, 1654–1664.e1.
- M ITSUHASHI, S., F ELDBRU¨ GGE, L., CSIZMADIA, E., MITSUHASHI, M., R OBSON, S. C. & MOSS, A. C. (2016). Luminal extracellular vesicles (EVs) in inflammatory bowel disease (IBD) exhibit proinflammatory effects on epithelial cells and macrophages. Inflammatory Bowel Diseases 22, 1587–1595.
- M OKARIZADEH, A., DELIREZH, N., MORSHEDI, A., M OSAYEBI, G., F ARSHID, A.-A. & MARDANI, K. (2012). Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunology Letters 147, 47–54.
- N AKATO, G., H ASE, K., S ATO, T., K IMURA, S., SAKAKIBARA, S., S UGIYAMA, M., O BATA, Y., H ANAZATO, M., I WANAGA, T. & O HNO, H. (2016). Epithelium-intrinsic microRNAs contribute to mucosal immune homeostasis by promoting M-cell maturation. PLoS One 11, e0150379.
- N EDAEINIA, R., M ANIAN, M., J AZAYERI, M. H., RANJBAR, M., S ALEHI, R., S HARIFI, M., MOHAGHEGH, F., GOLI, M., J AHEDNIA, S. H., A VAN, A. & GHAYOUR -MOBARHAN, M. (2017). Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Therapy 24, 48–56.
- O CANSEY, D. K. W., QIU, W., W ANG, J., YAN, Y., Q IAN, H., Z HANG, X., XU, W. & MAO, F. (2020). The achievements and challenges of mesenchymal stem cell-based therapy in inflammatory bowel disease and its associated colorectal cancer. Stem Cells International 2020, 1–18.
- O CANSEY, D. K. W., W ANG, L., W ANG, J., YAN, Y., QIAN, H., Z HANG, X., XU, W. & MAO, F. (2019). Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect. Clinical and Translational Medicine 8, 31.
- O KOYE, I. S., C OOMES, S. M., P ELLY, V. S., C ZIESO, S., P APAYANNOPOULOS, V., T OLMACHOVA, T., S EABRA, M. C. & W ILSON, M. S. (2014). MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity 41, 89–103.
- P ALMULLI, R. & VAN N IEL, G. (2018). To be or not to be… secreted as exosomes, a balance finely tuned by the mechanisms of biogenesis. Essays in Biochemistry 62, 177–191.
- P ARIZADEH, S. M., J AFARZADEH-E SFEHANI, R., GHANDEHARI, M., P ARIZADEH, S. M. R., H ASSANIAN, S. M., R EZAYI, M., GHAYOUR -M OBARHAN, M., F ERNS, G. A. & AVAN, A. (2019). Circulating exosomes as potential biomarkers in cardiovascular disease. Current Pharmaceutical Design 24, 4436–4444.
- P ARK, E. J., SHIMAOKA, M. & K IYONO, H. (2017). MicroRNA-mediated dynamic control of mucosal immunity. International Immunology 29, 157–163.
- P ASCUCCI, L., C OCCE`, V., B ONOMI, A., AMI, D., C ECCARELLI, P., C IUSANI, E., V IGANO, L., LOCATELLI, A., SISTO, F., DOGLIA, S. M., P ARATI, E., BERNARDO, M. E., MURACA, M.,

Biological Reviews 95 (2020) 1287–1307 © 2020 The Authors. Biological Reviews published by John Wiley & Sons Ltd on behalf of Cambridge Philosophical Society.